These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 73391)

  • 1. Effects of porcine plasmin on the coagulation and fibrinolytic systems in humans.
    Hedner U; Johansson L; Nilsson IM
    Blood; 1978 Jan; 51(1):157-64. PubMed ID: 73391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive coagulation induced by plasmin in patients treated with recombinant tissue-type plasminogen activator.
    Gram J; Munkvad S; Leebeek FW; Kluft C; Jespersen J
    Coron Artery Dis; 1993 Apr; 4(4):371-7. PubMed ID: 8261210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The coagulation and fibrinolytic enzyme system in pregnancy and in the puerperium.
    Beller FK; Ebert C
    Eur J Obstet Gynecol Reprod Biol; 1982 May; 13(3):177-97. PubMed ID: 6178627
    [No Abstract]   [Full Text] [Related]  

  • 4. The behavior of alpha2-plasmin inhibitor in fibrinolytic states.
    Aoki N; Moroi M; Matsuda M; Tachiya K
    J Clin Invest; 1977 Aug; 60(2):361-9. PubMed ID: 68962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a protease inhibitor, ulinastatin, on coagulation and fibrinolysis in abdominal surgery.
    Nishiyama T; Yokoyama T; Yamashita K
    J Anesth; 2006; 20(3):179-82. PubMed ID: 16897236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disequilibrium of Blood Coagulation and Fibrinolytic System in Patients With Coronary Artery Ectasia.
    Wu W; Liu R; Chen L; Chen H; Zhang S
    Medicine (Baltimore); 2016 Feb; 95(8):e2779. PubMed ID: 26937905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay.
    Harpel PC
    J Clin Invest; 1981 Jul; 68(1):46-55. PubMed ID: 6166634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
    Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
    Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin.
    Aoki N; Moroi M; Tachiya K
    Thromb Haemost; 1978 Feb; 39(1):22-31. PubMed ID: 77050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New neonatal problems of blood coagulation and fibrinolysis. I. The change of plasmin inhibitor levels in the newborn infant.
    Suzuki S; Wake N; Yoshiaki K
    J Perinat Med; 1976; 4(4):213-20. PubMed ID: 64604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of plasmin and its complexes with alpha 2-antiplasmin and alpha 2-macroglobulin on secretion of proteinase and plasminogen inhibitors from peripheral mononuclear cells].
    Zhabin SG; Zorin NA; Musatov MI
    Vopr Med Khim; 1995; 41(3):34-7. PubMed ID: 8585176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulative and fibrinolytic studies on postmenopausal women treated with a new non-steroidal oestrogen.
    Kullander S; Svanberg L; Astedt B
    Acta Obstet Gynecol Scand; 1977; 56(4):371-4. PubMed ID: 74933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
    Shaaban MM; Elwan SI; el-Kabsh MY; Farghaly SA; Thabet N
    Contraception; 1984 Nov; 30(5):421-30. PubMed ID: 6440738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activation in vivo upon intravenous infusion of DDAVP. Quantitative assessment of plasmin-alpha 2-antiplasmin complex with a novel monoclonal antibody based radioimmunoassay.
    Levi M; de Boer JP; Roem D; ten Cate JW; Hack CE
    Thromb Haemost; 1992 Jan; 67(1):111-6. PubMed ID: 1377412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation-fibrinolysis system in poststroke patients receiving antiplatelet medication.
    Tohgi H; Takahashi H; Chiba K; Tamura K
    Stroke; 1993 Jun; 24(6):801-4. PubMed ID: 8506551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of blood coagulation and fibrinolysis during and after hydroxyethyl starch (HES) colloidal volume replacement.
    Omar MN; Shouk TA; Khaleq MA
    Clin Biochem; 1999 Jun; 32(4):269-74. PubMed ID: 10463819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation and fibrinolytic reactions in experimental porcine septic shock: pretreatment with different antiplatelet factors.
    Svartholm E; Bergqvist D; Haglund U; Ljungberg J; Hedner U
    Circ Shock; 1987; 22(4):291-301. PubMed ID: 2443265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmin inhibitors and fibrinogen breakdown during the initial phase of thrombolytic treatment--the problem of the alpha 2-antiplasmin determination.
    Noll G; Lämmle B; Duckert F
    Thromb Haemost; 1984 Jul; 51(3):334-7. PubMed ID: 6238441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of non cross-linked and cross-linked fibrin clots by plasmin, trypsin, chymotrypsin and Brinase.
    Gormsen J; Feddersen C
    Thromb Res; 1974 Aug; 5(2):125-39. PubMed ID: 4278050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.